Waichi Wong Ruth-Ann Lee Susan L Saidman Rex Neal Smith Emmanuel Zorn
Clin Transpl
2009;401-5.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/20524305/
Boronic Acids / therapeutic use Graft Rejection / drug therapy Kidney Transplantation / immunology Protease Inhibitors / therapeutic use Pyrazines / therapeutic use
Boronic Acids / therapeutic use Graft Rejection / drug therapy Kidney Transplantation / immunology Protease Inhibitors / therapeutic use Pyrazines / therapeutic use Case Reports Adult Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Murine-Derived Antilymphocyte Serum / therapeutic use B-Lymphocytes / immunology Bortezomib Female Graft Rejection / prevention & control HLA Antigens / immunology Histocompatibility Testing Humans Immunoglobulins, Intravenous / therapeutic use Immunosuppressive Agents / therapeutic use Male Renal Dialysis Rituximab T-Lymphocytes / immunology Treatment Failure Treatment Outcome Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antilymphocyte Serum Boronic Acids HLA Antigens Immunoglobulins, Intravenous Immunosuppressive Agents Protease Inhibitors Pyrazines Rituximab Bortezomib
PMC3744373
20524305
Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports
2009